Viewing Study NCT00167869



Ignite Creation Date: 2024-05-05 @ 11:53 AM
Last Modification Date: 2024-10-26 @ 9:15 AM
Study NCT ID: NCT00167869
Status: COMPLETED
Last Update Posted: 2008-05-29
First Post: 2005-09-12

Brief Title: LACTOPRESStudy on the Effect of Dairy Peptides on Blood Pressure in Untreated Hypertensive Subjects
Sponsor: Wageningen University
Organization: Wageningen University

Study Overview

Official Title: LACTOPRESStudy on the Effect of Dairy Peptides on Blood Pressure in Untreated Hypertensive Subjects
Status: COMPLETED
Status Verified Date: 2008-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Hypertension is an increasingly important medical and public health issue Literature suggests that there may be a role for dairy foods in the prevention and treatment of hypertension Recently it has been suggested that several peptides in milk proteins could have blood pressure lowering properties LACTOPRES is a randomised double-blind parallel trial to assess the blood pressure effect of an increased intake of dairy peptides in humans
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None